3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Leukemia, Myeloid, Acute
10
Myelodysplastic Syndromes
7
Lymphoma, Non-Hodgkin
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Hodgkin Disease
5
Multiple Myeloma
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Anemia, Refractory, with Excess of Blasts
4
Recurrence
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Leukemia, Myeloid, Accelerated Phase
3
Leukemia
3
Colorectal Neoplasms
3
Burkitt Lymphoma
3
Stomach Neoplasms
2
Sarcoma
2
Primary Myelofibrosis
2
Pancreatic Neoplasms
2
Neoplasm, Residual
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Melanoma
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Myelomonocytic, Juvenile
2
Interventions
Azacitidine
2
venetoclax
1
Vorinostat
1
Lenalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
GATA2 Deficiency
×
fludarabine phosphate
×
30 days
×
Clear all
No trials found.